Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled study
- 1 May 1981
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 80 (5), 1016-1022
- https://doi.org/10.1016/0016-5085(81)90075-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- DOUBLE-BLIND STUDY OF LEUCOCYTE INTERFERON ADMINISTRATION IN CHRONIC HBsAg-POSITIVE HEPATITISThe Lancet, 1980
- Fibroblast interferon treatment of a patient with chronic active hepatitisAmerican Journal Of Medicine, 1979
- HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.BMJ, 1978
- Trial of ribavirin for the treatment of HBsAg positive chronic liver diseaseJournal of Antimicrobial Chemotherapy, 1978
- Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex EncephalitisNew England Journal of Medicine, 1977
- INTEGRATOR ENZYME HYPOTHESIS FOR REPLICATION OF HEPATITIS-B VIRUSThe Lancet, 1975
- DNA and DNA polymerase in the core of the Dane particle of hepatitis BThe American Journal of the Medical Sciences, 1975
- D.N.A. POLYMERASE IN PREPARATIONS CONTAINING AUSTRALIA ANTIGENThe Lancet, 1971
- Rapid Screening Test for Detecting Hepatitis-Associated AntigenScience, 1970
- The Antiviral Activity of 9-β-D-Arabinofuranosyladenine (ARA-A)Chemotherapy, 1968